OTC Colon Cancer Screening Test Now Available in Pharmacies Across US
Drug Topics
FEBRUARY 27, 2024
Reese Pharmaceutical’s ColoTest has a suggested retail price of $19.99 and will also be sold on major retail shelves later this spring.
Drug Topics
FEBRUARY 27, 2024
Reese Pharmaceutical’s ColoTest has a suggested retail price of $19.99 and will also be sold on major retail shelves later this spring.
STAT
FEBRUARY 27, 2024
Change Healthcare’s recent cyberattack has hospitals, doctors’ offices, and pharmacies across the country reeling as they struggle to process claims and bill patients. Experts told STAT it’s a glaring example of the risk of consolidation in health care. Change, which is owned by UnitedHealth Group, is one of the nation’s largest insurance claim processing hubs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
FEBRUARY 27, 2024
If approved, KnowU will become the world’s first non-invasive blood glucose monitor introduced to the global marketplace.
STAT
FEBRUARY 27, 2024
A much-anticipated inquiry by U.S. antitrust regulators into pharmaceutical industry middlemen has been stymied because the companies have failed to provide many of the documents that, in some cases, were requested as far back as June 2022. The inquiry was begun by the Federal Trade Commission in response to the role that pharmacy benefit managers play in the cost of prescription medicines.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Fierce Healthcare
FEBRUARY 27, 2024
LOS ANGELES — Healthcare data and tech company Veradigm is picking up ScienceIO in a $140 million deal to build out large language models for healthcare. | Veradigm plans to use the company's platform to create its own proprietary large language models on its own massive dataset, which includes 400,000 providers and over 200 million patients.
STAT
FEBRUARY 27, 2024
When my wife, Laurie, completed her ninth in vitro fertilization cycle in the spring of 2000, we had more than 150 fertilized embryos in frozen storage at the Center for Reproductive Medicine and Infertility at the NewYork Presbyterian Hospital-Weill Medical College of Cornell University. We were not stockpiling them for later use. At the time, our son Henry was 5.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
FEBRUARY 27, 2024
An unprecedented shortage of cholera vaccine has public health experts fearing that a recent surge of outbreaks across developing countries will only worsen, a situation they argue is as regrettable as it was avoidable. At least 16 countries in Asia, Africa, and the Caribbean are dealing with cholera outbreaks. According to the latest report from the European Centre for Disease Prevention and Control , between Dec. 23 and Jan. 23, nearly 50,500 people contracted cholera and nearly 500 died.
Drug Topics
FEBRUARY 27, 2024
Survey data from nationally conducted studies of pharmacist practice settings including community, health system, and clinical pharmacy are consistently showing between 40-60% reporting job dissatisfaction and/or burnout
Fierce Healthcare
FEBRUARY 27, 2024
Nearly all physicians in the U.S. | Nearly all physicians in the U.S. said they feel regularly burned out and over half of them have considered either leaving the profession or adopting non-patient-facing roles, according to a new Athenahealth survey.
Drug Topics
FEBRUARY 27, 2024
The new approval is supported by the phase 3 Study 4030, which evaluated the efficacy, safety, and tolerability profile of Biktarvy in a broad range of people with HIV-1 with or without pre-existing NRTI resistance, including those with the M184V/I resistance.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Pharma
FEBRUARY 27, 2024
Over-the-counter self-care specialist Perrigo is poised to leave hundreds of workers by the wayside as it embarks on the next leg of its corporate journey. | As part of a cost-cutting and restructuring initiative dubbed "Project Energize," Perrigo expects to trim roughly 6% of its total staff, the company said in a fourth-quarter earnings release Tuesday.
STAT
FEBRUARY 27, 2024
The Canadian surgeon and urologist Balfour Mount is considered the father of palliative care in North America. He was inspired and mentored by Cicely Saunders, a British nurse and social worker. Before she became a physician, Saunders developed the first modern hospice , St Christopher’s in London in 1967. Mount adapted and transplanted approaches to the care of the terminally ill he had learned at St Christopher’s to the Royal Victoria Hospital in Montreal.
Fierce Healthcare
FEBRUARY 27, 2024
Insurtech Alignment Healthcare has recorded $1.82 billion in revenue for full-year 2023 and beat market expectations for quarterly revenue by more than $20 million, the company announced Feb. | Alignment Healthcare stressed it should reach profitability this year and announced it would pulling back from the ACO REACH program, the company said during a fourth-quarter earnings call.
pharmaphorum
FEBRUARY 27, 2024
Next-generation technology is enabling drug discovery at an entirely new scale, accelerating the process, transforming therapies and advancing precision medicine, and resulting in better patient outcomes. In this podcast, Dr Mohit Jain, founder and CEO of Sapient, discusses personalised disease prediction, diagnostics, and therapies.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Drug Store News
FEBRUARY 27, 2024
DSN spoke to Cosnova founder Christina Oster-Daum and Jill Krakowski, chief marketing officer, USA, about the company’s growth, plans for the year ahead and how social media has played a key role in the popularity of its brands.
European Pharmaceutical Review
FEBRUARY 27, 2024
The Chief Executive of the Medicines and Healthcare products Regulatory Agency (MHRA), Dame June Raine, will step down in the Autumn following five years in the role. Dame June will remain in the position until then to support the new Chief Executive’s transition into the role. Leading the MHRA – a five year journey Professor Graham Cooke, interim chair of the MHRA board, remarked that Dame June’s “leadership of the MHRA over the last five years, particularly during the COVID-19 pand
pharmaphorum
FEBRUARY 27, 2024
The FDA has approved Allecra Therapeutics' Exblifep, a combination antibiotic for complicated urinary tract infections (cUTIs) that will now launch later this year, but turned down a rival product from Venatorx.
Fierce Pharma
FEBRUARY 27, 2024
AstraZeneca and FibroGen have finally reached the end of the road for their U.S. collaboration on the oral anemia drug roxadustat. | More than two years after a high-profile FDA rejection, AstraZeneca has backed out of a collaboration with FibroGen for the latter’s oral anemia drug roxadustat in the U.S. Still, AZ left the partners' China pact intact.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
European Pharmaceutical Review
FEBRUARY 27, 2024
Amgen has opened a new biomanufacturing plant in Central Ohio, US. It is the company ’s most advanced manufacturing facility to date. The new facility, known as Amgen Ohio, “was designed with the latest innovation and technology to deliver safe, reliable medicines for ‘every patient, every time,'” stated Robert Bradway, Chairman and Chief Executive Officer at Amgen. “As part of Amgen’s global biomanufacturing network, Amgen Ohio will play an important role in helping us
Drug Store News
FEBRUARY 27, 2024
iA’s NEXiA software now enables central fill operations with the ability to monetize excess capacity within a central fulfillment operation while providing operations across multiple pharmacy providers.
Fierce Healthcare
FEBRUARY 27, 2024
PE-backed anesthesiology group ends contracts with 5 Colorado hospitals, phases out non-competes to resolve monopoly inquiry dmuoio Tue, 02/27/2024 - 15:40
Drug Store News
FEBRUARY 27, 2024
Food Lion Feeds is helping provide nonperishable food to eight Historically Black Colleges and Universities that are part of the Central Intercollegiate Athletic Association.
pharmaphorum
FEBRUARY 27, 2024
Europe's commercial leaders are gearing up for a faster trial-to-treatment pathway, leveraging CRM technology to empower HCPs and sales teams.
The Checkup by Singlecare
FEBRUARY 27, 2024
You might not know that ED (erectile dysfunction) is associated with other health issues—like high blood pressure (also known as hypertension). In a SingleCare survey , high blood pressure was reported or believed to be the most common physical cause of ED. High blood pressure medications can sometimes alleviate erectile dysfunction by reducing stress on the blood vessels and allowing more normal blood flow.
Drug Store News
FEBRUARY 27, 2024
The brand’s new Softening Collection offers four new products that not only wash but hydrate and help style strands that may otherwise be over-processed, dry or dull.
pharmaphorum
FEBRUARY 27, 2024
Looking to the future of clinical trials: Gene therapy, precision medicine, and the ongoing quest for rare disease solutions Mike.
STAT
FEBRUARY 27, 2024
An obesity medication from Viking Therapeutics succeeded in a Phase 2 clinical study, the company said Tuesday, helping patients lose up to nearly 15% of their weight over about three months and further fueling the competition in the exploding obesity drug market. Shares of the San Diego-based company doubled in premarket trading. The trial tested four different weekly injectable doses of the Viking drug, called VK2735, over 13 weeks, with patients seeing a dose-dependent amount of
pharmaphorum
FEBRUARY 27, 2024
UK cancer survival is lagging 10-15 years behind other countries due to lower rates of chemotherapy and radiotherapy, says UCL study backed by CRUK.
Outsourcing Pharma
FEBRUARY 27, 2024
Biogen Inc. has announced a significant advancement in the treatment of amyotrophic lateral sclerosis (ALS), commonly known as motor neuron disease (MND).
pharmaphorum
FEBRUARY 27, 2024
FDA has turned down Minerva Neurosciences' marketing application for roluperidone as a treatment for the negative symptoms of schizophrenia
Fierce Healthcare
FEBRUARY 27, 2024
LOS ANGELES — Optum Health CEO Amar Desai took the stage at ViVE on Monday morning to discuss the company's value-based care ambitions and strategy, but there was a clear elephant in the room: | LOS ANGELES — Optum Health CEO Amar Desai took the stage at ViVE on Monday morning to discuss the company's value-based care ambitions and strategy, but there was a clear elephant in the room: the cyberattack on Change Healthcare that's still causing disruption nationwide.
pharmaphorum
FEBRUARY 27, 2024
UK biotech Curve Therapeutics raises $51 million in a Pfizer-led Series A that will support its platform for screening drugs within cells.
Outsourcing Pharma
FEBRUARY 27, 2024
Biogen Inc. has announced a significant advancement in the treatment of amyotrophic lateral sclerosis (ALS), commonly known as motor neuron disease (MND).
Let's personalize your content